Concurrent Investment Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
HGIM
DC
CF
MIHAS
MR
Concurrent Investment Advisors's ELV Position: Q2 2026 in Review
Concurrent Investment Advisors reduced its Elevance Health (ELV) stake by 0.21% in Q2 2026, selling an estimated $2.97K and leaving 3,725 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #846.
Concurrent Investment Advisors first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. 466 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Concurrent Investment Advisors held 3,725 shares of Elevance Health worth $1.44M as of Q2 2026.
- Concurrent Investment Advisors sold 8 Elevance Health shares in Q2 2026, an estimated $2.97K.
- Elevance Health made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #846 holding.
- Concurrent Investment Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
- 466 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.